{"id":231221,"date":"2026-02-12T22:02:53","date_gmt":"2026-02-13T04:02:53","guid":{"rendered":"https:\/\/lifeboat.com\/blog\/2026\/02\/genflow-reports-positive-interim-data-from-sirt6-gene-therapy-trial-in-aged-dogs"},"modified":"2026-02-12T22:02:53","modified_gmt":"2026-02-13T04:02:53","slug":"genflow-reports-positive-interim-data-from-sirt6-gene-therapy-trial-in-aged-dogs","status":"publish","type":"post","link":"https:\/\/lifeboat.com\/blog\/2026\/02\/genflow-reports-positive-interim-data-from-sirt6-gene-therapy-trial-in-aged-dogs","title":{"rendered":"Genflow reports positive interim data from SIRT6 gene therapy trial in aged dogs"},"content":{"rendered":"<p><a class=\"aligncenter blog-photo\" href=\"https:\/\/lifeboat.com\/blog.images\/genflow-reports-positive-interim-data-from-sirt6-gene-therapy-trial-in-aged-dogs.jpg\"><\/a><\/p>\n<p>First dogs, then \u2026<\/p>\n<hr>\n<p>\n<em><strong>Biotechnology group says treated animals showed improved survival and functional measures in early-stage study<\/strong><\/em><\/p>\n<p><a href=\"https:\/\/www.proactiveinvestors.com.au\/LON: GENF\/Genflow-Biosciences-Ltd\/\">Genflow Biosciences Ltd (LSE: GENF, OTCQB: GENFF, FRA: WQ5)<\/a> said positive preliminary interim results from its SLAB clinical trial showed improved survival and functional outcomes in aged dogs treated with its proprietary SIRT6 centenarian gene therapy.<\/p>\n<p>The biotechnology company, which focuses on developing gene therapies for age-related diseases, said the randomised, blinded study enrolled 24 beagle dogs aged over 10 years and was conducted by an independent contract research organisation.<\/p>\n","protected":false},"excerpt":{"rendered":"<p>First dogs, then \u2026 Biotechnology group says treated animals showed improved survival and functional measures in early-stage study Genflow Biosciences Ltd (LSE: GENF, OTCQB: GENFF, FRA: WQ5) said positive preliminary interim results from its SLAB clinical trial showed improved survival and functional outcomes in aged dogs treated with its proprietary SIRT6 centenarian gene therapy. The [\u2026]<\/p>\n","protected":false},"author":692,"featured_media":0,"comment_status":"open","ping_status":"closed","sticky":false,"template":"","format":"standard","meta":{"footnotes":""},"categories":[11,269],"tags":[],"class_list":["post-231221","post","type-post","status-publish","format-standard","hentry","category-biotech-medical","category-life-extension"],"_links":{"self":[{"href":"https:\/\/lifeboat.com\/blog\/wp-json\/wp\/v2\/posts\/231221","targetHints":{"allow":["GET"]}}],"collection":[{"href":"https:\/\/lifeboat.com\/blog\/wp-json\/wp\/v2\/posts"}],"about":[{"href":"https:\/\/lifeboat.com\/blog\/wp-json\/wp\/v2\/types\/post"}],"author":[{"embeddable":true,"href":"https:\/\/lifeboat.com\/blog\/wp-json\/wp\/v2\/users\/692"}],"replies":[{"embeddable":true,"href":"https:\/\/lifeboat.com\/blog\/wp-json\/wp\/v2\/comments?post=231221"}],"version-history":[{"count":0,"href":"https:\/\/lifeboat.com\/blog\/wp-json\/wp\/v2\/posts\/231221\/revisions"}],"wp:attachment":[{"href":"https:\/\/lifeboat.com\/blog\/wp-json\/wp\/v2\/media?parent=231221"}],"wp:term":[{"taxonomy":"category","embeddable":true,"href":"https:\/\/lifeboat.com\/blog\/wp-json\/wp\/v2\/categories?post=231221"},{"taxonomy":"post_tag","embeddable":true,"href":"https:\/\/lifeboat.com\/blog\/wp-json\/wp\/v2\/tags?post=231221"}],"curies":[{"name":"wp","href":"https:\/\/api.w.org\/{rel}","templated":true}]}}